Depletion of Endothelial or Smooth Muscle Cell-Specific Angiotensin II Type 1a Receptors Does Not Influence Aortic Aneurysms or Atherosclerosis in LDL Receptor Deficient Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Rateri, Debra L ^a   Moorleghen, Jessica J ^a   Knight, Victoria ^a   Balakrishnan, Anju ^a   Howatt, Deborah A ^a   Cassis, Lisa A ^b   Daugherty, Alan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; CRE RECOMBINASE; LOW DENSITY LIPOPROTEIN RECEPTOR; SATURATED FATTY ACID; TRANSGELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL SPECIFICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FAT INTAKE; FEMALE; GENE DELETION; MALE; NONHUMAN; PATHOGENESIS; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; BLOOD PRESSURE; CHROMATOGRAPHY, GEL; CROSSES, GENETIC; DIET, HIGH-FAT; ENDOTHELIAL CELLS; FEMALE; GENOTYPE; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, LDL;

MUS;

EID: 84870944164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051483     Document Type: Article

References (58)

1. Lu H, Balakrishnan A, Howatt DA, Wu C, Charnigo R, et al. (2012) Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol 165: 2000-2008.
2. Kowala MC, Grove RL, Aberg G (1994) Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis 61-72.
3. Schuh JR, Blehm DJ, Frierdich GE, Mcmahon EG, Blaine EH, (1993) Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 91: 1453-1458.
4. Aberg G, Ferrer P, (1990) Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 15: S65-S72.
5. Lu H, Rateri DL, Feldman DL, Charnigo RJ Jr, Fukamizu A, et al. (2008) Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118: 984-993.
6. Nussberger J, Aubert JF, Bouzourene K, Pellegrin M, Hayoz D, et al. (2008) Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension 51: 1306-1311.
7. Imanishi T, Tsujioka H, Ikejima H, Kuroi A, Takarada S, et al. (2008) Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 52: 563-572.
8. Daugherty A, Manning MW, Cassis LA, (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612.
9. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, et al. (2003) Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 92: 510-517.
10. Uchida HA, Poduri A, Subramanian V, Cassis LA, Daugherty A, (2011) Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. Arterio Thromb Vasc Biol 31: 2845-2852.
11. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-97.
12. Li J, Hirose N, Kawamura M, Arai Y, (1999) Antiatherogenic effect of angiotensin converting enzyme inhibitor (Benazepril) and angiotensin II receptor antagonist (Valsartan) in the cholesterol-fed rabbits. Atherosclerosis 143: 315-326.
13. Strawn WB, Chappell MC, Dean RH, Kivlighn S, Ferrario CM, (2000) Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 101: 1586-1593.
14. Wassmann S, Czech T, Van Eickels M, Fleming I, Bohm M, et al. (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/Angiotensin II type 1A receptor double-knockout mice. Circulation 110: 3062-3067.
15. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA, (2004) Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110: 3849-3857.
16. Li Z, Iwai M, Wu L, Liu HW, Chen R, et al. (2004) Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 44: 758-763.
17. Fukuda D, Sata M, Ishizaka N, Nagai R, (2007) Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 28: 72-77.
18. Cassis LA, Rateri DL, Lu H, Daugherty A, (2007) Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27: 380-386.
19. Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, et al. (2008) The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis. Hypertens Res 31: 1631-1642.
20. Daugherty A, Manning MW, Cassis LA, (2001) Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134: 865-870.
21. Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, et al. (2008) Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Hypertens Res 31: 1791-1800.
22. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, et al. (2011) Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Arterioscler Thromb Vasc Biol 31: 2856-2864.
23. Kato H, Ishida J, Nagano K, Honjo K, Sugaya T, et al. (2008) Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab Invest 88: 731-739.
24. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP III, Howatt DA, et al. (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res 108: 574-581.
25. Daugherty A, Cassis L, (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann NY Acad Sci 892: 108-118.
26. Daugherty A, Rateri DL, (1994) Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol-fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 14: 2017-2024.
27. Daugherty A, Rateri D, Lu H, Balakrishnan A (2009) Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp 1291.
28. Daugherty A, Whitman SC, (2003) Quantification of atherosclerosis in mice. Methods Mol Biol 209: 293-309.
29. Daugherty A, Rateri DL, (2005) Development of experimental designs for atherosclerosis studies in mice. Methods 36: 129-138.
30. Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, et al. (2006) Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg 44: 372-376.
31. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, et al. (2010) Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond) 118: 681-689.
32. Lu H, Cassis LA, Daugherty A, (2007) Atherosclerosis and arterial blood pressure in mice. Curr Drug Targets 8: 1181-1189.
33. Schiller NK, Kubo N, Boisvert WA, Curtiss LK, (2001) Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 21: 1674-1680.
34. Zhang X, Thatcher SE, Rateri DL, Bruemmer D, Charnigo R, et al. (2012) Transient Exposure of Neonatal Female Mice to Testosterone Abrogates the Sexual Dimorphism of Abdominal Aortic Aneurysms. Circ Res 110: e73-85.
35. Saraff K, Babamusta F, Cassis LA, Daugherty A, (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626.
36. Lu H, Rateri DL, Daugherty A, (2007) Immunostaining of mouse atherosclerosis lesions. Methods Mol Med 139: 77-94.
37. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM (2012) Six Commercially Available Angiotensin II AT(1) Receptor Antibodies are Non-specific. Cell Mol Neurobiol Epub.
38. Poduri A, Owens AP III, Howatt DA, Moorleghen JJ, Balakrishnan A, et al. (2012) Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS ONE 7: e48462.
39. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, et al. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651.
40. Kim JA, Berliner JA, Nadler JL, (1996) Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Comm 226: 862-868.
41. Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, et al. (1997) Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 81: 804-811.
42. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A, (2012) Involvement of the renin-angiotensin system in abdominal and throacic aortic aneurysms. Clin Sci 123: 531-543.
43. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA, (2009) Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 29: 1458-1464.
44. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A III, et al. (2009) An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 119: 3637-3651.
45. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis- A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 14: 840-856.
46. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374.
47. Reddick RL, Zhang SH, Maeda N, (1994) Atherosclerosis in mice lacking apo E- Evaluation of lesional development and progression. Arterioscler Thromb Vacsc Biol 14: 141-147.
48. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK, (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93: 1885-1893.
49. Subramanian V, Golledge J, Ijaz T, Bruemmer D, Daugherty A, (2010) Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Circ Res 107: 953-958.
50. Wolfsgruber W, Feil S, Brummer S, Kuppinger O, Hofmann F, et al. (2003) A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells. Proc Natl Acad Sci USA 100: 13519-13524.
51. Boucher P, Gotthardt M, Li WP, Anderson RGW, Herz J, (2003) LRP: Role in vascular wall integrity and protection from atherosclerosis. Science 300: 329-332.
52. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM, (1998) Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83: 952-959.
53. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, et al. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2: 275-281.
54. Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, et al. (2011) Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 57: 577-585.
55. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, et al. (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103: 17985-17990.
56. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, et al. (2011) AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475.
57. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA, (2004) Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 145: 3866-3872.
58. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA, (2008) Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 28: 1251-1256.